Premium
Polyoxazoline‐Peptide adducts that retain antibody avidity
Author(s) -
Velander William H.,
Madurawe Rapti D.,
Subramanian Anuradha,
Kumar Guneet,
SinaiZingde Gurudas,
Riffle Judy S.,
Orthner Carolyn L.
Publication year - 1992
Publication title -
biotechnology and bioengineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 189
eISSN - 1097-0290
pISSN - 0006-3592
DOI - 10.1002/bit.260391006
Subject(s) - avidity , adduct , peptide , chemistry , polymer , monoclonal antibody , solubility , peg ratio , combinatorial chemistry , polyethylene glycol , biochemistry , antibody , organic chemistry , polymer chemistry , biology , finance , economics , immunology
Synthetic polymers have long been used to modify various properties of proteins such as activity and solubility. Polyethylene glycol (PEG) has been widely used to form adducts with enzymes and antibodies. In this study, the polyoxazoline family of water‐soluble polymers was used to synthesize adducts containing a synthetic peptide recognized by a monoclonal antibody (MAb) directed against human protein C (hPC). This is the first application of direct conjugation of unterminated or “living” polymer to a peptide. The avidity of the antibody for the various adducts was characterized with respect to size and hydrophilicity of methyl‐ and ethyl‐substituted polyoxazoline polymers (POX). Avidity of the adducts was not found to be dependent upon the hydrophilicity and was slightly decreased due to polymer modification. The methyl‐POX‐peptide adducts were found to be highly water soluble, while the ethyl‐POX‐peptide adducts showed sporadic problems with aqueous solubility. Because the polymer‐peptide adducts retained avidity for the antibody, polyoxazoline polymers may have potential application to protein‐adduct chemistry.